Full Text View
Tabular View
No Study Results Posted
Related Studies
Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2007 by Logan College of Chiropractic.   Recruitment status was  Recruiting

First Received on July 31, 2007.   Last Updated on August 1, 2007   History of Changes
Sponsor: Logan College of Chiropractic
Information provided by: Logan College of Chiropractic
ClinicalTrials.gov Identifier: NCT00510523
  Purpose

The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in participants with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.


Condition Intervention
Multiple Sclerosis
Device: Whole Body Vibration machine

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

Resource links provided by NLM:


Further study details as provided by Logan College of Chiropractic:

Primary Outcome Measures:
  • NeuroCom Balance Master
  • SF-EMG Nerve conduction velocity test
  • Berg balance score

Estimated Enrollment: 80
Study Start Date: October 2006
Estimated Study Completion Date: November 2007
  Eligibility

Ages Eligible for Study:   25 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)

Exclusion Criteria:

  • Visual or vestibular condition that would affect balance
  • Non-Ms related systemic illness that would have an adverse effect on balance
  • Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes
  • Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates
  • Acute thrombosis
  • Severe migraine, epilepsy
  • Serious cardiovascular disease, wearing a pacemaker
  • Any Spinal manipulation within 48 hours
  • Acute disc herniation, discopathy or spondylolysis
  • Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance
  • Any implanted device or prosthesis or intrauterine IUD type of device
  • Pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00510523

Contacts
Contact: Dennis Enix, DC, MBA 636-227-2100 ext 1951 dennis.enix@logan.edu

Locations
United States, Missouri
Logan University, College of Chirpractic Recruiting
Chesterfield, Missouri, United States, 63017
Contact: LaShandra M Cheuvront, BA     636-230-1952     lashandra.cheuvront@logan.edu    
Principal Investigator: Dennis Enix, DC            
Logan University, College of Chiropractic Recruiting
Chesterfield, Missouri, United States, 63017
Contact: Dennis E. Enix, DC     636-227-2100 ext 1951     dennis.enix@logan.edu    
Principal Investigator: Dennis E. Enix, DC            
Sponsors and Collaborators
Logan College of Chiropractic
Investigators
Principal Investigator: Dennis Enix, DC, MBA Logan College of Chiropractic
Principal Investigator: Dennis Enix, DC, MBA Logan University
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00510523     History of Changes
Other Study ID Numbers: RD0731060030
Study First Received: July 31, 2007
Last Updated: August 1, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Logan College of Chiropractic:
MS
Balance
Multiple Sclerosis

Additional relevant MeSH terms:
Multiple Sclerosis
Sclerosis
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on February 09, 2012